Nationally representative trends and geographic variation in treatment of localized prostate cancer: the Urologic Diseases in America project.

Variation in Care for Patients with Irritable Bowel Syndrome in the United States. PLoS One (2016) 0.75

Transplants for MDS and quality-of-life. But whose quality-of-life? Bone Marrow Transplant (2016) 0.75

The early adoption of intensity-modulated radiotherapy and stereotactic body radiation treatment among older Medicare beneficiaries with prostate cancer. Cancer (2017) 0.75

Geographic Variations and Time Trends in Cancer Treatments in Taiwan. BMC Public Health (2017) 0.75

Cancer statistics, 2013. CA Cancer J Clin (2013) 84.72

Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol (2010) 8.93

Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med (1997) 8.72

Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol (2006) 8.58

Risk of fracture after androgen deprivation for prostate cancer. N Engl J Med (2005) 8.32

6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial. JAMA (2004) 8.10

EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol (2010) 7.20

Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol (2007) 6.73

Determinants of androgen deprivation therapy use for prostate cancer: role of the urologist. J Natl Cancer Inst (2006) 3.10

Impact of age at diagnosis on prostate cancer treatment and survival. J Clin Oncol (2010) 2.89

Geographic and socioeconomic variation in the treatment of prostate cancer. J Clin Oncol (2005) 2.41

Men older than 70 years have higher risk prostate cancer and poorer survival in the early and late prostate specific antigen eras. J Urol (2009) 1.85

Quality of life of asymptomatic men with nonmetastatic prostate cancer on androgen deprivation therapy. J Urol (2000) 1.84

High-risk prostate cancer in the United States, 1990-2007. World J Urol (2008) 1.83

Understanding variation in primary prostate cancer treatment within the Veterans Health Administration. Urology (2012) 1.62

Pathological staging and biochemical recurrence after neoadjuvant androgen deprivation therapy in combination with radical prostatectomy in clinically localized prostate cancer: results of a phase II study. Br J Urol (1997) 1.55

Patient preferences in prostate cancer: a clinician's guide to understanding health utilities. Clin Prostate Cancer (2005) 1.33

Androgen deprivation therapy in prostate cancer: are rising concerns leading to falling use? BJU Int (2011) 0.98

Counterpoint: robot-assisted laparoscopic prostatectomy: perhaps the surgical gold standard for prostate cancer care. J Natl Compr Canc Netw (2007) 0.88

Utilization trends in prostate cancer therapy. J Urol (2011) 0.86

Memory complaints associated with the use of gonadotropin-releasing hormone agonists: a preliminary study. Fertil Steril (1996) 0.84

Emergency department revisits for patients with kidney stones in California. Acad Emerg Med (2015) 1.56

The impact of unplanned postprocedure visits in the management of patients with urinary stones. Surgery (2013) 0.99

Quality of Acute Care for Patients With Urinary Stones in the United States. Urology (2015) 0.85

Updated trends in imaging use in men diagnosed with prostate cancer. Prostate Cancer Prostatic Dis (2014) 0.82

Obesity and prostate cancer-specific mortality after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Prostate Cancer Prostatic Dis (2016) 0.75

Acute health care utilization and outcomes for outpatient-treated urinary tract infections in children. J Pediatr Urol (2016) 0.75